Pablo Francisco Belaunzarán-Zamudio

15PUBLICATIONS
53CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Behavioural epidemiologyAutoimmunityGroundwater quality processes and contaminated land assessmentMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2026
Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study.

|Mar 18, 2026
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

John R Koethe, Jordan E Lake, Amy Kantor

|Apr 29, 2024
The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.

Jordan E Lake, Douglas W Kitch, Amy Kantor

|Aug 08, 2023
Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trials.

Jessica Mejía-Castrejón, Juan Gerardo Sierra-Madero, Pablo Francisco Belaunzarán-Zamudio

|Jan 04, 2023
Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.

Pablo F Belaunzarán-Zamudio, Lizbeth Naranjo, Yanink Caro-Vega

|Nov 17, 2022
Guillain-Barré syndrome outbreak in Tapachula temporally associated with the Zika virus introduction in Southern Mexico.

Ricardo Paul Rodríguez de la Rosa, J Oggún Cano-Torres, Sonia Rosales

Pageof 3

Frequent Collaborators

3 joint publications

Brenda E Crabtree-Ramírez

3 joint publications

Kristine M Erlandson

2 joint publications

Jordan E Lake

2 joint publications

Paola Del Carmen Guerra-de-Blas